Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

49.91
Delayed Data
As of 11:05am ET
 -0.09 / -0.18%
Today’s Change
35.07
Today|||52-Week Range
54.96
+1.94%
Year-to-Date
Bristol-Myers to Not Seek Accelerated Approval for Opdivo+Yervoy
10:02am / Zacks.com - Paid Partner Content
Bioblast (ORPN) SCA3 Drug Favorable in Phase IIa Study
Jan 19 / Zacks.com - Paid Partner Content
Aduro (ADRO) Inks License Agreement with Stanford University
9:20am / Zacks.com - Paid Partner Content
Allergan's Uterine Fibroids Candidate Positive in Phase III
Jan 18 / Zacks.com - Paid Partner Content
Mallinckrodt to Pay $100M Fine to FTC for Questcor Matter
Jan 19 / Zacks.com - Paid Partner Content
Concert Offers Update on Cystic Fibrosis Drug, Stock Down
Jan 18 / Zacks.com - Paid Partner Content
Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan 19 / Zacks.com - Paid Partner Content
Kura Oncology Starts Dosing Patients in Phase II CMML Study
Jan 18 / Zacks.com - Paid Partner Content
Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval
Jan 19 / Zacks.com - Paid Partner Content
Benitec Stock Up on Orphan Drug Status for BB-301 in EU
Jan 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close50.00
Today’s open50.28
Day’s range49.83 - 50.28
Volume32,658
Average volume (3 months)109,354
Market cap$731.2M
Dividend yield--
Data as of 11:05am ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-19.92%
Earnings growth (this year)+6.47%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.93%
P/E ratio21.4
Price/Sales6.29
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
CSIICardiovascular Syste...-0.12-0.48%
BEATBioTelemetry Inc-0.30-1.34%
ANGOAngioDynamics Inc+0.01+0.06%
ATRIAtrion Corp+3.65+0.78%
Data as of 11:20am ET, 01/20/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$0.53
Annual revenue (last year)$93.0M
Annual profit (last year)$30.8M
Net profit margin33.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Dana M. Alexander
Corporate headquarters
Bedford, Massachusetts

Forecasts


Search for Jobs